Form 4 for JCI Johnson Controls
Accepted 2025-05-08 00:00:00 ET · period of report 2025-05-08 · accession 0001127602-25-013754 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-08 | 2025-05-08 | JCI | Vandiepenbeeck Marc | EVP, CFO | S - Sale+OE | $90.92 | -28.3K | 170.7K | -14% | -$2.57M |
| DM | 2025-05-08 | 2025-05-08 | JCI | Vandiepenbeeck Marc | EVP, CFO | M - OptEx | $43.58 | +23.0K | 176.0K | +15% | +$1.00M |
| DM | 2025-05-08 | 2025-05-08 | JCI | Vandiepenbeeck Marc | EVP, CFO | M - OptEx | $0.00 | -23.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-05-08 | S | D | 23,028 | $90.96 | 147,673.33 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.70 to $91.35 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Ordinary Shares | 2025-05-08 | M | A | 12,345 | $41.75 | 165,279.33 | D | — | — | |
| 3 | Common | Ordinary Shares | 2025-05-08 | M | A | 10,683 | $45.69 | 175,962.33 | D | — | — | |
| 4 | Common | Ordinary Shares | 2025-05-08 | S | D | 5,261 | $90.77 | 170,701.33 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.69 to $90.87 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2025-05-08 | M | D | 12,345 | $0.00 | 0 | D | $41.75 · 2021-12-05 to 2029-12-05 | 12,345 Ordinary Shares | (F3) Options became exercisable in four equal installments on each of the first, second, third and fourth anniversary of the grant date. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2025-05-08 | M | D | 10,683 | $0.00 | 0 | D | $45.69 · 2022-12-10 to 2030-12-10 | 10,683 Ordinary Shares | (F3) Options became exercisable in four equal installments on each of the first, second, third and fourth anniversary of the grant date. |